Skip to content

Clinical trials

Phase 3 Conjunctivitis, Allergic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Conjunctivitis, Allergic Phase: Phase 3 Country / region: United States Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20062
20074
20081
20093
20101
20123
20132
20151
20183
20191
20211
20221
20231
20242
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vistakon Pharmaceuticals9
Bausch & Lomb Incorporated7
Regeneron Pharmaceuticals5
Aciex Therapeutics, Inc.3
Akorn, Inc.1
Aldeyra Therapeutics, Inc.1
Allergan1
Dompé Farmaceutici S.p.A1
Eleven Biotherapeutics1
Faes Farma, S.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Conjunctivitis, Allergic32
Asthma1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.